{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:59:06Z","timestamp":1763564346565,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005765","name":"Universidade de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005765","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute kidney injury (AKI) is a multifactorial condition often induced by drugs commonly used in hospitals. Identifying and staging AKI necessitates frequent monitoring of renal function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>To assess the impact of real-world hospital practices regarding serum creatinine (SCr) testing on the identification and staging of AKI, and its implications for adjusting drug doses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>A historical cohort study utilizing hospital records from all adult patients admitted between 01\/06\/2018 and 31\/12\/2020 was conducted. Patients with no SCr assessment during their stay or those with an SCr at admission\u2009\u2265\u20092\u00a0mg\/dL were excluded. AKI was determined using two criteria, namely AKIN and KDIGO, considering the time intervals between two SCr tests as outlined in the criteria. Additionally, patients with SCr increases exceeding AKI limits, regardless the time interval, were also identified. The estimated glomerular filtration rate (eGFR) and kinetic eGFR (KeGFR) were calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the study period, 17,269 hospitalizations and 62,255 SCr tests were recorded. Among the 17,032 hospitalizations with a length of stay\u2009&gt;\u200948\u00a0h, 46.8% experienced periods with no SCr tests performed for more than 48\u00a0h. Any stage of AKI was identified in 7.0% of patients and in 9.1% using AKI and KDIGO criteria, respectively. Ignoring time limits in both criteria revealed potential AKI in 1942 patients (11.2%), indicating a potential underdiagnosis of AKI by 37.5% or 19.1%, depending on the criteria used. A total of 76 drugs requiring dose adjustment in patients with eGFR\u2009\u2264\u200950\u00a0ml\/min were prescribed in 78.5% admissions. These drugs were prescribed in 87.9% of patients potentially underdiagnosed with AKIN and in 88.9% with KDIGO.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There is a need for changes in the established hospital procedures to ensure more frequent testing of SCr levels. Implementing an advanced scope of practice for clinical pharmacists could support these changes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11096-023-01697-4","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T14:02:41Z","timestamp":1707141761000},"page":"623-630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of inpatient creatinine testing frequency on acute kidney injury identification and staging: a historical cohort study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6218-2717","authenticated-orcid":false,"given":"Catarina Luz","family":"Oliveira","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6632-2553","authenticated-orcid":false,"given":"Filipa","family":"Duarte-Ramos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-2514","authenticated-orcid":false,"given":"Filipa","family":"Alves da Costa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-9595","authenticated-orcid":false,"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"issue":"11","key":"1697_CR1","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365\u201370. https:\/\/doi.org\/10.1681\/ASN.2004090740.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1697_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.2215\/CJN.05191107","volume":"3","author":"SS Waikar","year":"2008","unstructured":"Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008;3(3):844\u201361. https:\/\/doi.org\/10.2215\/CJN.05191107.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1697_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s11096-020-01147-5","volume":"42","author":"SM Magboul","year":"2020","unstructured":"Magboul SM, Osman B, Elnour AA. The incidence, risk factors, and outcomes of acute kidney injury in the intensive care unit in Sudan. Int J Clin Pharm. 2020;42(6):1447\u201355. https:\/\/doi.org\/10.1007\/s11096-020-01147-5.","journal-title":"Int J Clin Pharm"},{"issue":"22","key":"1697_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3238\/arztebl.2019.0397","volume":"116","author":"D Khadzhynov","year":"2019","unstructured":"Khadzhynov D, Schmidt D, Hardt J, et al. The incidence of acute kidney injury and associated hospital mortality. Dtsch Arztebl Int. 2019;116(22):397\u2013404. https:\/\/doi.org\/10.3238\/arztebl.2019.0397.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"1697_CR5","first-page":"733","volume":"78","author":"CY Goh","year":"2023","unstructured":"Goh CY, Visvanathan R, Leong CT, et al. A prospective study of incidence and outcome of acute kidney injury among hospitalised patients in Malaysia (My-AKI). Med J Malaysia. 2023;78(6):733\u201342.","journal-title":"Med J Malaysia"},{"issue":"1","key":"1697_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Eggers PW, Star RA, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58\u201366. https:\/\/doi.org\/10.1056\/NEJMra1214243.","journal-title":"N Engl J Med"},{"issue":"9","key":"1697_CR7","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s40620-022-01381-2","volume":"35","author":"K Stille","year":"2022","unstructured":"Stille K, Kribben A, Herget-Rosenthal S. Incidence, severity, risk factors and outcomes of acute kidney injury in older adults: systematic review and meta-analysis. J Nephrol. 2022;35(9):2237\u201350. https:\/\/doi.org\/10.1007\/s40620-022-01381-2.","journal-title":"J Nephrol"},{"issue":"4","key":"1697_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/0885066607299510","volume":"22","author":"R Venkataraman","year":"2007","unstructured":"Venkataraman R, Kellum JA. Defining acute renal failure: the RIFLE criteria. J Intens Care Med. 2007;22(4):187\u201393. https:\/\/doi.org\/10.1177\/0885066607299510.","journal-title":"J Intens Care Med"},{"issue":"2","key":"1697_CR9","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. https:\/\/doi.org\/10.1186\/cc5713.","journal-title":"Crit Care"},{"issue":"4","key":"1697_CR10","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384. https:\/\/doi.org\/10.1159\/000339789.","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"1697_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/ndt\/gfp392","volume":"25","author":"J Bouchard","year":"2010","unstructured":"Bouchard J, Macedo E, Soroko S, et al. Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. Nephrol Dial Transpl. 2010;25(1):102\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfp392.","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"1697_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2215\/CJN.0000000000000101","volume":"18","author":"ML Behal","year":"2023","unstructured":"Behal ML, Flannery AH, Barreto EF. Medication management in the critically Ill patient with acute kidney injury. Clin J Am Soc Nephrol. 2023;18(8):1080\u20138. https:\/\/doi.org\/10.2215\/CJN.0000000000000101.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1697_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.mayocp.2018.08.002","volume":"94","author":"EF Barreto","year":"2019","unstructured":"Barreto EF, Rule AD, Murad MH, et al. Prediction of the renal elimination of drugs with cystatin C vs creatinine: a systematic review. Mayo Clin Proc. 2019;94(3):500\u201314. https:\/\/doi.org\/10.1016\/j.mayocp.2018.08.002.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"1697_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1681\/ASN.2012070653","volume":"24","author":"S Chen","year":"2013","unstructured":"Chen S. Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely. J Am Soc Nephrol. 2013;24(6):877\u201388. https:\/\/doi.org\/10.1681\/ASN.2012070653.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1697_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s11096-022-01453-0","volume":"44","author":"OY Alshogran","year":"2022","unstructured":"Alshogran OY, Hajjar MH, Muflih SM, et al. The role of clinical pharmacist in enhancing hemodialysis patients\u2019 adherence and clinical outcomes: a randomized-controlled study. Int J Clin Pharm. 2022;44(5):1169\u201378. https:\/\/doi.org\/10.1007\/s11096-022-01453-0.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"1697_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s11096-019-00796-5","volume":"41","author":"KS Choi","year":"2019","unstructured":"Choi KS, Lee E, Rhie SJ. Impact of pharmacists\u2019 interventions on physicians\u2019 decision of a knowledge-based renal dosage adjustment system. Int J Clin Pharm. 2019;41(2):424\u201333. https:\/\/doi.org\/10.1007\/s11096-019-00796-5.","journal-title":"Int J Clin Pharm"},{"key":"1697_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/IPRP.S52930","volume":"4","author":"BL McDaniel","year":"2015","unstructured":"McDaniel BL, Bentley ML. The role of medications and their management in acute kidney injury. Integr Pharm Res Pract. 2015;4:21\u20139. https:\/\/doi.org\/10.2147\/IPRP.S52930.","journal-title":"Integr Pharm Res Pract"},{"key":"1697_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2147\/PPA.S397873","volume":"17","author":"J Hou","year":"2023","unstructured":"Hou J, Li JF, Yan XJ, et al. The effect of clinical pharmacist intervention on renal function impairment in patients with antimicrobial-induced acute kidney injury in ICU. Patient Prefer Adherence. 2023;17:711\u20138. https:\/\/doi.org\/10.2147\/PPA.S397873.","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"1697_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.20344\/amp.11280","volume":"32","author":"C Meneses-Oliveira","year":"2019","unstructured":"Meneses-Oliveira C. Use of electronic medical records for research: new ethical challenges and possible solutions. Acta Med Port. 2019;32(5):332\u20134. https:\/\/doi.org\/10.20344\/amp.11280.","journal-title":"Acta Med Port"},{"key":"1697_CR20","volume-title":"The renal drug handbook","author":"C Ashley","year":"2009","unstructured":"Ashley C, Currie A. The renal drug handbook. 3rd ed. Abingdon: Radcliffe Publishing; 2009.","edition":"3"},{"issue":"9","key":"1697_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"key":"1697_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000484962","volume":"193","author":"M Fiorentino","year":"2018","unstructured":"Fiorentino M, Grandaliano G, Gesualdo L, et al. Acute kidney injury to chronic kidney disease transition. Contrib Nephrol. 2018;193:45\u201354. https:\/\/doi.org\/10.1159\/000484962.","journal-title":"Contrib Nephrol"},{"key":"1697_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000329396","volume":"174","author":"LS Chawla","year":"2011","unstructured":"Chawla LS. Acute kidney injury leading to chronic kidney disease and long-term outcomes of acute kidney injury: the best opportunity to mitigate acute kidney injury? Contrib Nephrol. 2011;174:182\u201390. https:\/\/doi.org\/10.1159\/000329396.","journal-title":"Contrib Nephrol"},{"key":"1697_CR24","doi-asserted-by":"publisher","unstructured":"Section 2: Definition and classification of AKI. Kidney Int Suppl (2011). 2012;2(1):19\u201336. https:\/\/doi.org\/10.1038\/kisup.2011.32","DOI":"10.1038\/kisup.2011.32"},{"issue":"1","key":"1697_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semnephrol.2016.01.008","volume":"36","author":"BA Molitoris","year":"2016","unstructured":"Molitoris BA, Reilly ES. Quantifying Glomerular Filtration Rates in Acute Kidney Injury: A Requirement for Translational Success. Semin Nephrol. 2016;36(1):31\u201341. https:\/\/doi.org\/10.1016\/j.semnephrol.2016.01.008.","journal-title":"Semin Nephrol"},{"issue":"2","key":"1697_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/ckj\/sfw108","volume":"10","author":"ED O'Sullivan","year":"2017","unstructured":"O\u2019Sullivan ED, Doyle A. The clinical utility of kinetic glomerular filtration rate. Clin Kidney J. 2017;10(2):202\u20138. https:\/\/doi.org\/10.1093\/ckj\/sfw108.","journal-title":"Clin Kidney J"},{"issue":"3","key":"1697_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5527\/wjn.v4.i3.330","volume":"4","author":"F Keller","year":"2015","unstructured":"Keller F, Schroppel B, Ludwig U. Pharmacokinetic and pharmacodynamic considerations of antimicrobial drug therapy in cancer patients with kidney dysfunction. World J Nephrol. 2015;4(3):330\u201344. https:\/\/doi.org\/10.5527\/wjn.v4.i3.330.","journal-title":"World J Nephrol"},{"key":"1697_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-023-01656-z","author":"N Janus","year":"2023","unstructured":"Janus N, Desplanques PY. How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations. Int J Clin Pharm. 2023. https:\/\/doi.org\/10.1007\/s11096-023-01656-z.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1697_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1517\/17425255.2013.835802","volume":"10","author":"BJ Philips","year":"2014","unstructured":"Philips BJ, Lane K, Dixon J, et al. The effects of acute renal failure on drug metabolism. Expert Opin Drug Metab Toxicol. 2014;10(1):11\u201323. https:\/\/doi.org\/10.1517\/17425255.2013.835802.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"1697_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5527\/wjn.v6.i4.176","volume":"6","author":"CJ Wiedermann","year":"2017","unstructured":"Wiedermann CJ, Wiedermann W, Joannidis M. Causal relationship between hypoalbuminemia and acute kidney injury. World J Nephrol. 2017;6(4):176\u201387. https:\/\/doi.org\/10.5527\/wjn.v6.i4.176.","journal-title":"World J Nephrol"},{"key":"1697_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare7010010","author":"VE Blanco","year":"2019","unstructured":"Blanco VE, Hernandorena CV, Scibona P, et al. Acute kidney injury pharmacokinetic changes and its impact on drug prescription. Healthcare (Basel). 2019. https:\/\/doi.org\/10.3390\/healthcare7010010.","journal-title":"Healthcare (Basel)"},{"issue":"11","key":"1697_CR32","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ki.2011.322","volume":"80","author":"GR Matzke","year":"2011","unstructured":"Matzke GR, Aronoff GR, Atkinson AJ Jr, et al. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80(11):1122\u201337. https:\/\/doi.org\/10.1038\/ki.2011.322.","journal-title":"Kidney Int"},{"issue":"1","key":"1697_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11096-020-00970-0","volume":"42","author":"RJ Zaal","year":"2020","unstructured":"Zaal RJ, den Haak EW, Andrinopoulou ER, et al. Physicians\u2019 acceptance of pharmacists\u2019 interventions in daily hospital practice. Int J Clin Pharm. 2020;42(1):141\u20139. https:\/\/doi.org\/10.1007\/s11096-020-00970-0.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"1697_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s11096-018-0660-6","volume":"40","author":"CV Coulter","year":"2018","unstructured":"Coulter CV. The role of the suspicious renal pharmacist in identifying unusual adverse drug reactions-why this is not a small problem. Int J Clin Pharm. 2018;40(4):775\u20137. https:\/\/doi.org\/10.1007\/s11096-018-0660-6.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"1697_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11096-020-01016-1","volume":"42","author":"S Sukkha","year":"2020","unstructured":"Sukkha S, Rattanavipanon W, Chamroenwit B, et al. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand. Int J Clin Pharm. 2020;42(2):610\u20136. https:\/\/doi.org\/10.1007\/s11096-020-01016-1.","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"1697_CR36","doi-asserted-by":"publisher","first-page":"100734","DOI":"10.1016\/j.xkme.2023.100734","volume":"5","author":"HP May","year":"2023","unstructured":"May HP, Herges JR, Anderson BK, et al. Posthospital multidisciplinary care for AKI survivors: a feasibility pilot. Kidney Med. 2023;5(12):100734. https:\/\/doi.org\/10.1016\/j.xkme.2023.100734.","journal-title":"Kidney Med"},{"key":"1697_CR37","doi-asserted-by":"publisher","DOI":"10.1159\/000535246","author":"P Thanapongsatorn","year":"2023","unstructured":"Thanapongsatorn P, Krisem M, Kaewnan K, et al. Effectiveness of multidisciplinary post-acute kidney injury clinic on awareness and knowledge in acute kidney injury survivors. Blood Purif. 2023. https:\/\/doi.org\/10.1159\/000535246.","journal-title":"Blood Purif"},{"key":"1697_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/10600280231171373","author":"JM Knight","year":"2023","unstructured":"Knight JM, Iso T, Perez KK, et al. Risk of acute kidney injury based on vancomycin target trough attainment strategy: area-under-the-curve-guided Bayesian software, nomogram, or trough-guided dosing. Ann Pharmacother. 2023. https:\/\/doi.org\/10.1177\/10600280231171373.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"1697_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.36518\/2689-0216.1502","volume":"4","author":"BLS Robinson","year":"2023","unstructured":"Robinson BLS, Bennie B, Nasiri M, et al. Implementing AUC monitoring in a pharmacist-managed vancomycin dosing protocol: a retrospective cohort study. HCA Healthc J Med. 2023;4(2):157\u201365. https:\/\/doi.org\/10.36518\/2689-0216.1502.","journal-title":"HCA Healthc J Med"},{"issue":"4","key":"1697_CR40","doi-asserted-by":"publisher","first-page":"e071968","DOI":"10.1136\/bmjopen-2023-071968","volume":"13","author":"AM Aklilu","year":"2023","unstructured":"Aklilu AM, O\u2019Connor KD, Martin M, et al. Personalised recommendations for hospitalised patients with acute kidney injury using a kidney action team (KAT-AKI): protocol and early data of a randomised controlled trial. BMJ Open. 2023;13(4):e071968. https:\/\/doi.org\/10.1136\/bmjopen-2023-071968.","journal-title":"BMJ Open"},{"issue":"9","key":"1697_CR41","first-page":"1962","volume":"48","author":"JP Peterson","year":"1991","unstructured":"Peterson JP, Colucci VJ, Schiff SE. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs. Am J Hosp Pharm. 1991;48(9):1962\u20134.","journal-title":"Am J Hosp Pharm"},{"issue":"9","key":"1697_CR42","first-page":"1965","volume":"48","author":"DE Goldberg","year":"1991","unstructured":"Goldberg DE, Baardsgaard G, Johnson MT, et al. Computer-based program for identifying medication orders requiring dosage modification based on renal function. Am J Hosp Pharm. 1991;48(9):1965\u20139.","journal-title":"Am J Hosp Pharm"},{"issue":"3","key":"1697_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.18553\/jmcp.2020.26.3.320","volume":"26","author":"HM Delgado","year":"2020","unstructured":"Delgado HM, Kleinman NP, Makarem AF, et al. Implementing California senate bill 493 in an outpatient pharmacy within an integrated health system: evaluation of the operational and clinical effect of pharmacist-ordered laboratory tests. J Manag Care Spec Pharm. 2020;26(3):320\u20134. https:\/\/doi.org\/10.18553\/jmcp.2020.26.3.320.","journal-title":"J Manag Care Spec Pharm"},{"key":"1697_CR44","doi-asserted-by":"publisher","first-page":"E81","DOI":"10.5888\/pcd15.170485","volume":"15","author":"PA Gheewala","year":"2018","unstructured":"Gheewala PA, Peterson GM, Zaidi STR, et al. Australian community pharmacists\u2019 experience of implementing a chronic kidney disease risk assessment service. Prev Chronic Dis. 2018;15:E81. https:\/\/doi.org\/10.5888\/pcd15.170485.","journal-title":"Prev Chronic Dis"},{"key":"1697_CR45","doi-asserted-by":"publisher","first-page":"811289","DOI":"10.3389\/fphar.2022.811289","volume":"13","author":"A Durand","year":"2022","unstructured":"Durand A, Gillibert A, Membre S, et al. Acceptance factors for in-hospital pharmacist interventions in daily practice: a retrospective study. Front Pharmacol. 2022;13:811289. https:\/\/doi.org\/10.3389\/fphar.2022.811289.","journal-title":"Front Pharmacol"},{"key":"1697_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3233\/SHTI230368","volume":"304","author":"R Marcilly","year":"2023","unstructured":"Marcilly R, Colliaux J, Payen A, et al. Considering work systems and processes in assessing the impact of a CDSS intervention: preliminary results. Stud Health Technol Inform. 2023;304:52\u20136. https:\/\/doi.org\/10.3233\/SHTI230368.","journal-title":"Stud Health Technol Inform"},{"key":"1697_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-023-01677-8","author":"MM Castel-Branco","year":"2023","unstructured":"Castel-Branco MM, Lavrador M, Cabral AC, et al. Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study. Int J Clin Pharm. 2023. https:\/\/doi.org\/10.1007\/s11096-023-01677-8.","journal-title":"Int J Clin Pharm"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01697-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-023-01697-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01697-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:41:08Z","timestamp":1716921668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-023-01697-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1007\/s11096-023-01697-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"assertion":[{"value":"9 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FAC is associate editor of the International Journal of Clinical Pharmacy but was not involved in the review process of this manuscript. The other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}